Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease
文献类型：期刊论文
| 作者 | Huang, Xiao-Tian1,3; Qian, Zhong-Ming2; He, Xuan1; Gong, Qi1; Wu, Ka-Chun1; Jiang, Li-Rong2; Lu, Li-Na1; Zhu, Zhou-jing1; Zhang, Hai-Yan3 ; Yung, Wing-Ho1
|
| 刊名 | NEUROBIOLOGY OF AGING
 |
| 出版日期 | 2014-05 |
| 卷号 | 35期号:5页码:1045-1054 |
| 关键词 | Huperzine A Alzheimer's disease Brain iron Transferrin receptor 1 Double transgenic APPswe/PS1dE9 mice (APP/PS mice) The neuronal amyloid precursor protein (APP) |
| ISSN号 | 0197-4580 |
| DOI | 10.1016/j.neurobiolaging.2013.11.004 |
| 文献子类 | Article |
| 英文摘要 | Huperzine A (HupA), a natural inhibitor of acetylcholinesterase derived from a plant, is a licensed anti-Alzheimer's disease (AD) drug in China and a nutraceutical in the United States. In addition to acting as an acetylcholinesterase inhibitor, HupA possesses neuroprotective properties. However, the relevant mechanism is unknown. Here, we showed that the neuroprotective effect of HupA was derived from a novel action on brain iron regulation. HupA treatment reduced insoluble and soluble beta amyloid levels, ameliorated amyloid plaques formation, and hyperphosphorylated tau in the cortex and hippocampus of APPswe/PS1dE9 transgenic AD mice. Also, HupA decreased beta amyloid oligomers and amyloid precursor protein levels, and increased A Disintegrin And Metalloprotease Domain 10 (ADAM10) expression in these treated AD mice. However, these beneficial effects of HupA were largely abolished by feeding the animals with a high iron diet. In parallel, we found that HupA decreased iron content in the brain and demonstrated that HupA also has a role to reduce the expression of transferrin-receptor 1 as well as the transferrin-bound iron uptake in cultured neurons. The findings implied that reducing iron in the brain is a novel mechanism of HupA in the treatment of Alzheimer's disease. (C) 2014 Elsevier Inc. All rights reserved. |
| WOS关键词 | AMYLOID-PRECURSOR-PROTEIN ; TRANSFERRIN-BOUND IRON ; TRANSGENIC MICE ; RAT-BRAIN ; NEURODEGENERATIVE DISORDERS ; EXPRESSION ; CERULOPLASMIN ; TRANSPORT ; PATHWAYS ; KINASE |
| 资助项目 | Competitive Earmarked Grants of The Hong Kong Research Grants Council[GRF 466713] ; National Basic Research Program of China (973 Program)[2011CB510004] ; General Grant of National Natural Science Foundation of China (NSFC)[31271132-2012] ; General Grant of National Natural Science Foundation of China (NSFC)[31371092-2013] ; Key Project Grant of NSFC[31330035-2013] ; Chinese University of Hong Kong[4054042] |
| WOS研究方向 | Geriatrics & Gerontology ; Neurosciences & Neurology |
| 语种 | 英语 |
| WOS记录号 | WOS:000332308300011 |
| 出版者 | ELSEVIER SCIENCE INC |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/277108]  |
| 专题 | 药理学第二研究室 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
| 通讯作者 | Ke, Ya |
| 作者单位 | 1.Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; 2.Fudan Univ, Sch Pharm, Neuropharmacol Lab, Shanghai 200433, Peoples R China; 3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China |
| 推荐引用方式 GB/T 7714 | Huang, Xiao-Tian,Qian, Zhong-Ming,He, Xuan,et al. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease[J]. NEUROBIOLOGY OF AGING,2014,35(5):1045-1054. |
| APA | Huang, Xiao-Tian.,Qian, Zhong-Ming.,He, Xuan.,Gong, Qi.,Wu, Ka-Chun.,...&Ke, Ya.(2014).Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.NEUROBIOLOGY OF AGING,35(5),1045-1054. |
| MLA | Huang, Xiao-Tian,et al."Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease".NEUROBIOLOGY OF AGING 35.5(2014):1045-1054. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。